Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Oncolytics Bio (ONC.TO)

Oncolytics Bio (ONC.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 112,375
  • Shares Outstanding, K 75,420
  • Annual Sales, $ 0 K
  • Annual Income, $ -27,752 K
  • 60-Month Beta 1.12
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.08
Trade ONC.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.41
  • Most Recent Earnings $-0.05 on N/A
  • Latest Earnings Date 05/03/24
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Biotechnology

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.12
  • Number of Estimates 2
  • High Estimate -0.11
  • Low Estimate -0.12
  • Prior Year -0.10
  • Growth Rate Est. (year over year) -20.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.37 +7.30%
on 03/27/24
1.75 -16.00%
on 04/04/24
+0.09 (+6.52%)
since 03/26/24
3-Month
1.20 +22.50%
on 02/07/24
1.75 -16.00%
on 04/04/24
-0.17 (-10.37%)
since 01/26/24
52-Week
1.20 +22.50%
on 02/07/24
4.49 -67.26%
on 06/23/23
-0.27 (-15.52%)
since 04/26/23

Most Recent Stories

More News
Stocks in play: Oncolytics Biotech® Inc.

Announced the acceptance of two abstracts at the 2024 American Society of Clinical Oncology (ASCO) Annual ...

ONC.TO : 1.47 (-1.34%)
Stocks in play: Oncolytics Biotech Inc

Today announced the acceptance of two abstracts at the 2024 American Society of Clinical Oncology (ASCO) ...

ONC.TO : 1.47 (-1.34%)
Oncolytics Biotech® Announces Upcoming Presentations at the American Society of Clinical Oncology Annual Meeting

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced the...

ONCY : 1.0900 (+0.93%)
ONC.TO : 1.47 (-1.34%)
Biotech Breakthroughs Spearhead Fight Against Rising Breast Cancer Cases

USA News Group – The American Cancer Society is projecting 2024 to be the first year ever for the US to have more than 2 million new cases, which would represent a record high. Among 10 of the most common...

ONCY : 1.0900 (+0.93%)
ONC.TO : 1.47 (-1.34%)
GILD : 65.42 (+0.23%)
GTHX : 3.99 (+3.37%)
AZN : 75.17 (+0.19%)
HOLX : 75.98 (+0.36%)
Biotech Innovations Paving the Way in Breast Cancer Fight

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GILD),(NASDAQ:GTHX),(NASDAQ:AZN),(NASDAQ:HOLX) EQNX::TICKER_END

ONCY : 1.0900 (+0.93%)
ONC.TO : 1.47 (-1.34%)
GILD : 65.42 (+0.23%)
GTHX : 3.99 (+3.37%)
AZN : 75.17 (+0.19%)
HOLX : 75.98 (+0.36%)
Stocks in play: Oncolytics Biotech Inc

Announces the submission of a Type C meeting request to the FDA. This meeting aims to discuss the Company's ...

ONC.TO : 1.47 (-1.34%)
Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA

Requested for Q2 2024, the Type C meeting is to focus on planned registration-enabling trial in HR+/HER2- metastatic breast cancer Overall survival results from the randomized HR+/HER2- metastatic breast...

ONCY : 1.0900 (+0.93%)
ONC.TO : 1.47 (-1.34%)
Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapeutics for oncology, is pleased to...

ONCY : 1.0900 (+0.93%)
ONC.TO : 1.47 (-1.34%)
Stocks in play: Oncolytics Biotech Inc

Announced that President and Chief Executive Officer Dr. Matt Coffey will participate in the Viral Approaches ...

ONC.TO : 1.47 (-1.34%)
Oncolytics Biotech® to Participate in a Panel Presentation at Canaccord Genuity's Horizons in Oncology Virtual Conference

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a clinical-stage immunotherapeutics company focused on oncology, today announced that President...

ONCY : 1.0900 (+0.93%)
ONC.TO : 1.47 (-1.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the...

See More

Key Turning Points

3rd Resistance Point 1.53
2nd Resistance Point 1.51
1st Resistance Point 1.49
Last Price 1.47
1st Support Level 1.45
2nd Support Level 1.43
3rd Support Level 1.41

See More

52-Week High 4.49
Fibonacci 61.8% 3.23
Fibonacci 50% 2.84
Fibonacci 38.2% 2.46
Last Price 1.47
52-Week Low 1.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar